by H.S. Ayoub
BioHealth Investor.com
Biotechnology
OPEXA THERAPEUTICS [OPXA] +23.40%
POLYMEDIX INC [PYMX.OB] +18.38%
PIPEX PHARMACEUT NEW [PPEX.OB] +16.01%
BIOENVISION INC [BIVN] +12.79%
MEMORY PHARMACEUTICA [MEMY] +8.15%
Diagnostic Substances
REMOTEMDX INC [RMDX.OB] +9.68%
TORREYPINES THERAPEU [TPTX] +6.92%
EPICEPT CORPORATION [EPCT] +3.97%
ISTA PHARMACTLS [ISTA] +2.89%
EPIX PHARMACEUTICALS [EPIX] +2.75%
Drug Delivery
IOMED INC [IOX] +2.58%
BIOPROGRESS PLC [BPRG] +2.53%
BENTLEY PHARMACEUTIC [BNT] +2.48%
K V PHARMA CL A [KV-A] +2.22%
ELAN CP PLC ADR [ELN] +1.59%
Drug Manufacturers
DUSA PHARM INC [DUSA] +71.90%
AVANIR PHARMACEUTICL [AVNR] +21.76%
NEXMED INC [NEXM] +18.81%
GERON CORP [GERN] +15.05%
NEUROCHEM INC [NRMX] +7.61%
Drug Related Products
ZILA INC [ZILA] +1.10%
NATURAL ALTERNATIV [NAII] +0.65%
N B T Y INC [NTY] +0.43%
Generic Drugs
ISOLAGEN INC [ILE] +2.47%
PHARMACUTICAL CO [PRX] +1.59%
BARR PHARMA INC [BRL] +1.36%
CATALYST PHARMACEUTI [CPRX] +0.46%
WATSON PHARMACEUTCLS [WPI] +0.06%
Medical Appliances & Equipment
CELSION CORP [CLN] +15.66%
SONTRA MEDICAL CORP [SONT.OB] +9.23%
REGENERATION TECH [RTIX] +7.50%
AMER MED ALERT CP [AMAC] +5.71%
RESTORE MEDICAL INC [REST] +3.54%
Medical Instruments & Supplies
HEMOSENSE INC. [HEM] +11.95%
APA ENTERPRISES [APAT] +8.59%
EP MEDSYSTEMS INC [EPMD] +8.57%
ALPHATEC HOLDINGS [ATEC] +8.21%
IVAX DIAGNOSTICS INC [IVD] +7.96%
Medical Laboratories & Research
RADNET INC [RDNT] +3.28%
PHARM PROD DEV [PPDI] +2.99%
NATL DENTEX CP [NADX] +1.50%
AETERNA ZENTARIS [AEZS] +0.84%
BIO-IMAGING TECH [BITI] +0.46%
Sponsored: Attention Savvy Investors: Speak to 3 Financial Experts – FREE
Ever wanted an extra set of eyes on an investment you’re considering? Now you can speak with up to 3 financial experts in your area for FREE. By simply
clicking here you can begin to match with financial professionals who can help guide you through the financial decisions you’re making. And the best part? The first conversation with them is free.
Click here to match with up to 3 financial pros who would be excited to help you make financial decisions.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.